BBIO BridgeBio Pharma, Inc. - Common Stock
$84,70
Prezzo · Ago 19, 2026
Fondamentali al Ago 10, 2026
Intervallo 52 sett.
$47–$93
81% of range
Rating Analisti
BUY
28 analysts
Prezzo Obiettivo
$108
+28% upside
P/E (TTM)
-22.5
ROE
41.2%
Margine di Profitto Netto
-146.0%
BBIO Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$84.70
Capitalizzazione di Mercato
$16.58B
P/E (TTM)
-22.5
EPS (TTM)
$-3.78
Ricavi (TTM)
$502M
Rendimento div.
—
ROE
41.2%
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$47 – $93
BBIO Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$502M
2019-12-31
→
2025-12-31
EPS
$-3.78
2020-12-31
→
2025-12-31
Flusso di cassa libero
$-447M
2019-12-31
→
2025-12-31
Margini
-146.0%
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
BBIO
Mediana dei peer
P/E (TTM)
-22.5
28.5
P/S (TTM)
33.0
20.1
P/B
-7.9
12.9
Price / FCF (Prezzo / FCF)
-37.1
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
BBIO
Mediana dei peer
Operating Margin (Margine Operativo)
-104.2%
—
Net Profit Margin (Margine di Profitto Netto)
-146.0%
-48.4%
ROA
-79.0%
-28.4%
ROE
41.2%
-49.2%
ROIC
25.1%
—
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
BBIO
Mediana dei peer
Current Ratio (Rapporto corrente)
2.8
5.0
Quick Ratio
2.5
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
BBIO
Mediana dei peer
Revenue YoY (Ricavi YoY)
126.3%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
86.3%
—
Revenue CAGR 5Y (CAGR Ricavi 5Y)
127.4%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
BBIO
Mediana dei peer
BBIO Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
28 analisti
- Acquisto forte 6 21,4%
- Compra 19 67,9%
- Mantieni 3 10,7%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
21 analisti · 2026-08-16
Mediana
$108.00
Ora
$84.70
Basso
$80.00
Alto
$157.00
Target mediano
$108.00
+27,5%
Target medio
$108.43
+28,0%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-0.11%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $-0.78 | $-0.60 | -0.18% |
| 31 Marzo 2026 | $-0.84 | $-0.69 | -0.15% |
| 31 Dicembre 2025 | $-1.00 | $-0.76 | -0.24% |
| 30 Settembre 2025 | $-0.95 | $-0.91 | -0.04% |
| 30 Giugno 2025 | $-0.95 | $-0.86 | -0.09% |
| 31 Marzo 2025 | $-0.88 | $-0.94 | 0.06% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| BBIO | $14.90B | -20.2 | 126.3% | -146.0% | 41.2% | — |
| INSM | $37.29B | -27.1 | 66.7% | -210.5% | -128.4% | — |
| INCY | $19.60B | 15.4 | 21.2% | 25.0% | 27.6% | — |
| MRNA | $11.62B | -4.1 | -39.9% | -145.2% | -31.3% | — |
| UTHR | $21.27B | 17.5 | 10.6% | 41.9% | 18.7% | 87.9% |
| NBIX | $14.20B | 30.4 | 21.4% | 16.7% | 16.1% | — |
| EXEL | $11.44B | 15.7 | 7.0% | 33.7% | 37.3% | — |
| BMRN | $11.43B | 33.0 | 12.9% | 10.8% | 5.8% | — |
| ARWR | $4.68B | -3449.0 | 23258.2% | -0.20% | -0.50% | — |
| MDGL | $13.30B | -45.3 | 432.1% | -30.1% | -44.4% | — |
| HALO | $7.93B | 26.3 | 37.5% | 22.7% | 166.1% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 17
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $502M | $222M | $9M | $78M | $70M | $8M | $41M | |
| Cost of Revenue | $21M | $4M | $2M | $3M | $3M | · | · | |
| R&D Expense | $452M | $506M | $456M | $399M | $451M | $337M | $210M | |
| SG&A Expense | $531M | $289M | $151M | $143M | $192M | $146M | $94M | |
| Operating Expenses | $1.03B | $815M | $617M | $590M | $646M | $483M | $307M | |
| Operating Income | $-523M | $-593M | $-607M | $-512M | $-577M | $-474M | $-266M | |
| Interest Expense | · | · | $81M | $80M | $47M | $37M | $9M | |
| Interest Income | $20M | $17M | $18M | $8M | $1M | $4M | $9M | |
| Other Non-op | $43M | $12M | $17M | $-8M | $36M | $2M | $-2M | |
| Pretax Income | $-733M | $-542M | $-653M | $-485M | · | $505M | $289M | |
| Income Tax | $435.0K | $1M | $0 | $0 | · | · | · | |
| Net Income | $-733M | $-543M | $-653M | $-485M | $-586M | $-505M | $-289M | |
| EPS (Basic) | $-3.78 | $-2.88 | $-3.95 | $-3.26 | $-3.90 | $-3.80 | · | |
| EPS (Diluted) | $-3.78 | $-2.88 | $-3.95 | $-3.26 | $-3.90 | $-3.80 | · | |
| Shares (Basic) | 191,527,482 | 186,075,873 | 162,791,511 | 147,473,076 | 144,356,619 | 117,995,457 | · | |
| Shares (Diluted) | 191,527,482 | 186,075,873 | 162,791,511 | 147,473,076 | 144,356,619 | 117,995,457 | · | |
| EBITDA | $-518M | $-587M | $-601M | $-505M | $-571M | $-474M | $-266M |
Stato Patrimoniale 26
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $570M | $681M | $376M | $377M | $394M | $356M | $364M | |
| Short-term Investments | · | $0 | $0 | $52M | $394M | $251M | $182M | |
| Receivables | $139M | $5M | $2M | · | · | · | · | |
| Inventory | $27M | $0 | · | · | · | · | · | |
| Prepaid Expense | $44M | $35M | $24M | $22M | $32M | $36M | $20M | |
| Current Assets | $798M | $721M | $478M | $549M | $889M | $643M | $569M | |
| PP&E (Net) | $5M | $7M | $12M | $15M | $30M | $20M | $6M | |
| Intangibles | $28M | $24M | $26M | $29M | $45M | $0 | · | |
| Other Non-current Assets | $17M | $18M | $23M | $20M | $33M | $24M | $26M | |
| Total Assets | $936M | $919M | $546M | $623M | $1.01B | $704M | $632M | |
| Accounts Payable | $36M | $10M | $11M | $12M | $12M | $9M | $9M | |
| Accrued Liabilities | · | · | · | · | · | · | $3M | |
| Current Liabilities | $288M | $154M | $144M | $121M | $135M | $96M | $60M | |
| Capital Leases | $4M | $5M | $9M | $12M | $17M | $15M | · | |
| Other Non-current Liabilities | $244.0K | $286.0K | $6M | $27M | $22M | $10M | $4M | |
| Total Liabilities | $3.01B | $2.38B | $1.89B | $1.87B | $1.88B | $596M | $156M | |
| Long-term Debt | $2.01B | · | · | · | · | $94M | $95M | |
| Total Debt | · | $437M | $446M | $431M | $431M | $94M | $92M | |
| Common Stock | $202.0K | $196.0K | $181.0K | $157.0K | $154.0K | $125.0K | $124.0K | |
| Paid-in Capital | $2.06B | $1.90B | · | · | · | · | · | |
| Retained Earnings | $-3.82B | $-3.10B | $-2.56B | $-1.92B | $-1.44B | $-889M | $-440M | |
| Treasury Stock | $323M | $275M | $275M | $275M | $275M | $75M | · | |
| AOCI | $12.0K | $8.0K | $31.0K | $-328.0K | $-132.0K | $192.0K | $254.0K | |
| Stockholders' Equity | $-2.09B | $-1.47B | $-1.35B | $-1.25B | $-870M | $58M | $408M | |
| Liabilities + Equity | $936M | $919M | $546M | $623M | $1.01B | $704M | $632M | |
| Shares Outstanding | 194,771,957 | 190,044,473 | 175,082,951 | 150,625,572 | 147,343,323 | 122,849,389 | 123,658,287 |
Flusso di cassa 18
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $5M | $6M | $6M | $7M | $6M | $1M | $859.0K | |
| Stock-based Comp | $133M | $96M | $109M | $92M | $100M | $58M | $21M | |
| Deferred Tax | $0 | $0 | $0 | · | · | · | · | |
| Amort. of Intangibles | $3M | $2M | $2M | $2M | $3M | · | · | |
| Restructuring | · | $16M | $8M | $44M | $0 | $0 | · | |
| Other Non-cash | $149M | $-79M | $10M | $-33M | $-17M | · | · | |
| Operating Cash Flow | $-446M | $-521M | $-528M | $-419M | $-498M | $-400M | $-254M | |
| CapEx | $1M | $933.0K | $1M | $5M | $13M | $8M | $3M | |
| Investing Cash Flow | $-24M | $61M | $54M | $453M | $-201M | $-53M | $-217M | |
| Net Debt Issued | · | $-473M | $0 | $-20M | $-124M | · | · | |
| Stock Issued | $0 | $315M | $450M | $5M | $0 | $0 | · | |
| Stock Repurchased | $48M | $0 | $0 | $0 | $200M | $75M | · | |
| Net Stock Activity | $-48M | $315M | $144M | $5M | $-200M | $-75M | · | |
| Dividends Paid | · | · | · | · | · | · | $997.0K | |
| Financing Cash Flow | $359M | $748M | $452M | $-13M | $736M | $447M | $399M | |
| Net Change in Cash | $-111M | $289M | $-22M | $21M | $38M | $-6M | $-72M | |
| Taxes Paid | $1M | $0 | $0 | · | · | · | · | |
| Free Cash Flow | $-447M | $-522M | $-529M | $-424M | $-511M | $-407M | $-256M |
Redditività 7
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -104.2% | -267.2% | -6528.7% | -659.6% | -827.1% | -5752.0% | -656.4% | |
| Net Margin | -146.0% | -244.9% | -7021.9% | -624.2% | -841.2% | -6127.9% | -711.5% | |
| Pretax Margin | -145.9% | -244.3% | · | · | · | 6127.9% | 711.5% | |
| EBITDA Margin | -103.2% | -264.5% | -6458.9% | -650.9% | -818.7% | -5752.0% | -656.4% | |
| ROA | -79.0% | -74.1% | -111.7% | -59.2% | -68.3% | -75.7% | -52.6% | |
| ROE | 41.2% | 38.5% | 50.1% | 45.6% | 144.4% | -216.8% | -101.0% | |
| ROIC | 25.1% | 57.7% | · | · | · | · | · |
Liquidità e Solvibilità 5
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.8 | 4.7 | 3.3 | 4.5 | 6.6 | 6.7 | 9.4 | |
| Quick Ratio | 2.5 | 4.4 | 2.6 | 3.5 | 5.8 | 6.3 | 9.0 | |
| Debt / Equity | · | -0.3 | -0.3 | -0.3 | -0.5 | 1.6 | 0.2 | |
| LT Debt / Equity | · | -0.3 | -0.3 | -0.3 | -0.5 | 1.6 | 0.2 | |
| Interest Coverage | · | · | -7.5 | -6.4 | -12.3 | -12.9 | -30.4 |
Efficienza 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.3 | 0.0 | 0.1 | 0.1 | 0.0 | 0.1 | |
| Inventory Turnover | 1.6 | · | · | · | · | · | · | |
| Receivables Turnover | 7.0 | 68.6 | · | · | · | · | · |
Tassi di Crescita 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 126.3% | 2285.3% | -88.0% | 11.4% | 745.1% | · | · | |
| Revenue CAGR 3Y | 86.3% | 47.1% | 4.1% | · | · | · | · | |
| Revenue CAGR 5Y | 127.4% | · | · | · | · | · | · |
Valutazione (TTM) 17
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $502M | $222M | $9M | $78M | $70M | $8M | $41M | |
| Net Income TTM | $-733M | $-543M | $-653M | $-485M | $-586M | $-505M | $-289M | |
| Market Cap | $14.90B | $5.21B | $7.07B | $1.15B | $2.46B | $8.74B | $4.33B | |
| Enterprise Value | · | $4.97B | $7.14B | $1.15B | $2.10B | $8.22B | $3.88B | |
| P/E | -20.2 | -9.5 | -10.2 | -2.3 | -4.3 | -18.7 | · | |
| P/S | 29.7 | 23.5 | 759.8 | 14.8 | 35.3 | 1059.0 | 106.9 | |
| P/B | -7.1 | -3.6 | -5.2 | -0.9 | -2.8 | 150.9 | 10.6 | |
| P / Tangible Book | · | · | · | · | · | 150.9 | · | |
| P / Cash Flow | -33.4 | -10.0 | -13.4 | -2.7 | -4.9 | -21.9 | -17.1 | |
| P / FCF | -33.3 | -10.0 | -13.4 | -2.7 | -4.8 | -21.5 | -16.9 | |
| EV / EBITDA | · | -8.5 | -11.9 | -2.3 | -3.7 | -17.3 | -14.6 | |
| EV / FCF | · | -9.5 | -13.5 | -2.7 | -4.1 | -20.2 | -15.1 | |
| EV / Revenue | · | 22.4 | 767.3 | 14.8 | 30.1 | 996.8 | 95.7 | |
| Dividend Yield | · | · | · | · | · | · | 0.02% | |
| Earnings Yield | -4.9% | -10.5% | -9.8% | -42.8% | -23.4% | -5.3% | · | |
| Payout Ratio | · | · | · | · | · | · | -0.35% | |
| Annual Payout | · | · | · | · | · | · | $997.0K |
Conto Economico 17
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $244M | $195M | $154M | $121M | $111M | $117M | $6M | $3M | $2M | $211M | $2M | $4M | $2M | $2M | $2M | $338.0K | |
| Cost of Revenue | $15M | $10M | $8M | $7M | $4M | $3M | $2M | $598.0K | $598.0K | $598.0K | $598.0K | $598.0K | $599.0K | $651.0K | $647.0K | $739.0K | |
| R&D Expense | $149M | $127M | $116M | $113M | $111M | $111M | $130M | $120M | $115M | $141M | $130M | $125M | $107M | $93M | $91M | $93M | |
| SG&A Expense | $186M | $164M | $158M | $138M | $129M | $106M | $95M | $69M | $60M | $66M | $48M | $36M | $36M | $31M | $32M | $31M | |
| Operating Expenses | $351M | $300M | $294M | $266M | $245M | $221M | $232M | $194M | $178M | $211M | $179M | $162M | $148M | $128M | $131M | $129M | |
| Operating Income | $-107M | $-106M | $-140M | $-145M | $-134M | $-104M | $-226M | $-192M | $-176M | $343.0K | $-177M | $-158M | $-146M | $-126M | $-129M | $-129M | |
| Interest Expense | · | · | · | · | · | · | · | · | $23M | $23M | · | $20M | $21M | $20M | · | $20M | |
| Interest Income | $7M | $6M | $4M | $6M | $4M | $5M | $5M | $3M | $5M | $4M | $6M | $4M | $5M | $4M | $4M | $2M | |
| Other Non-op | $6M | $4M | $12M | $16M | $7M | $8M | $2M | $2M | $-632.0K | $9M | $22M | $-5M | $1M | $-601.0K | $5M | $6M | |
| Pretax Income | $-156M | · | $-195M | $-186M | $-182M | · | $-266M | $-164M | $-76M | · | · | · | · | · | · | · | |
| Income Tax | $0 | · | $-120.0K | $-2M | $2M | $0 | $1M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-156M | $-167M | $-195M | $-185M | $-184M | $-170M | $-267M | $-164M | $-76M | $-36M | $-170M | $-179M | $-161M | $-143M | $-141M | $-140M | |
| EPS (Basic) | $-0.78 | $-0.84 | $-1.00 | $-0.95 | $-0.95 | $-0.88 | $-1.43 | $-0.86 | $-0.39 | $-0.20 | $-0.97 | $-1.08 | $-0.98 | $-0.92 | $-0.91 | $-0.93 | |
| EPS (Diluted) | $-0.78 | $-0.84 | $-1.00 | $-0.95 | $-0.95 | $-0.88 | $-1.43 | $-0.86 | $-0.39 | $-0.20 | $-0.97 | $-1.08 | $-0.98 | $-0.92 | $-0.91 | $-0.93 | |
| Shares (Basic) | 195,785,884 | 194,789,897 | -380,989,138 | 191,854,152 | 190,517,215 | 190,145,253 | -368,726,489 | 188,510,372 | 187,586,680 | 178,705,310 | -313,698,191 | 163,308,632 | 160,535,435 | 152,645,635 | -293,031,694 | 147,937,817 | |
| Shares (Diluted) | 195,785,884 | 194,789,897 | -380,989,138 | 191,854,152 | 190,517,215 | 190,145,253 | -368,726,489 | 188,510,372 | 187,586,680 | 178,705,310 | -313,698,191 | 163,308,632 | 160,535,435 | 152,645,635 | -293,031,694 | 147,937,817 | |
| EBITDA | $-107M | $-105M | · | $-145M | $-134M | $-103M | · | $-192M | $-176M | $2M | · | $-158M | $-146M | $-125M | · | $-129M |
Stato Patrimoniale 25
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $678M | $880M | $570M | $643M | $749M | $541M | $681M | $266M | $408M | $475M | $376M | $505M | $302M | $407M | $377M | $483M | |
| Short-term Investments | · | · | · | · | $8M | · | · | · | $40M | $44M | · | $0 | $31M | $34M | · | $75M | |
| Receivables | $254M | $205M | $139M | $117M | $77M | $115M | $5M | · | · | · | · | · | · | · | · | · | |
| Inventory | $53M | $33M | $27M | $25M | $18M | $4M | $0 | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $66M | $63M | $44M | $52M | $60M | $35M | $35M | $38M | $28M | $28M | · | $23M | $21M | $25M | · | $26M | |
| Current Assets | $1.09B | $1.24B | $798M | $839M | $912M | $695M | $721M | $445M | $616M | $783M | · | $588M | $433M | $553M | · | $642M | |
| PP&E (Net) | $5M | $5M | $5M | $6M | $6M | $7M | $7M | $9M | $10M | $11M | · | $12M | $13M | $14M | · | $16M | |
| Intangibles | $27M | $27M | $28M | $29M | $30M | $28M | $24M | $25M | $25M | $26M | · | $27M | $28M | $28M | · | $29M | |
| Other Non-current Assets | $20M | $19M | $17M | $26M | $18M | $17M | $18M | $20M | $19M | $21M | · | $19M | $20M | $21M | · | $30M | |
| Total Assets | $1.22B | $1.37B | $936M | $998M | $1.08B | $882M | $919M | $665M | $794M | $849M | · | $655M | $504M | $626M | · | $729M | |
| Accounts Payable | $27M | $29M | $36M | $19M | $26M | $28M | $10M | $13M | $18M | $5M | · | $4M | $4M | $4M | · | $10M | |
| Current Liabilities | $891M | $816M | $288M | $217M | $176M | $152M | $154M | $139M | $134M | $141M | · | $106M | $110M | $97M | · | $119M | |
| Capital Leases | $15M | $14M | $4M | $3M | $4M | $5M | $5M | $6M | $7M | $8M | · | $10M | $11M | $12M | · | $13M | |
| Other Non-current Liabilities | $240.0K | $229.0K | $244.0K | $679.0K | $545.0K | $352.0K | $286.0K | $377.0K | $485.0K | $595.0K | · | $12M | $13M | $18M | · | $28M | |
| Total Liabilities | $3.72B | $3.64B | $3.01B | $2.92B | $2.86B | $2.52B | $2.38B | $1.88B | $1.88B | $1.89B | · | $1.85B | $1.85B | $1.84B | · | $1.86B | |
| Long-term Debt | $2.65B | $2.65B | $2.01B | $2.01B | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | · | · | · | · | $0 | $0 | · | $436M | $435M | $435M | · | $442M | $440M | $436M | · | · | |
| Common Stock | $206.0K | $204.0K | $202.0K | $200.0K | $198.0K | $197.0K | $196.0K | $195.0K | $194.0K | $193.0K | · | $180.0K | $168.0K | $167.0K | · | $156.0K | |
| Paid-in Capital | $2.16B | $2.11B | $2.06B | $2.02B | · | · | $1.90B | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-4.14B | $-3.99B | $-3.82B | $-3.63B | $-3.45B | $-3.26B | $-3.10B | $-2.83B | $-2.67B | $-2.60B | · | $-2.39B | $-2.22B | $-2.06B | · | $-1.78B | |
| Treasury Stock | $533M | $406M | $323M | $323M | $323M | $323M | $275M | $275M | $275M | $275M | · | $275M | $275M | $275M | · | $275M | |
| AOCI | $-7.0K | $-8.0K | $12.0K | $2.0K | $1.0K | $0 | $8.0K | $5.0K | $-4.0K | $2.0K | · | $34.0K | $63.0K | $-12.0K | · | $-348.0K | |
| Stockholders' Equity | $-2.52B | $-2.28B | $-2.09B | $-1.93B | $-1.79B | $-1.65B | $-1.47B | $-1.23B | $-1.09B | $-1.05B | · | $-1.21B | $-1.36B | $-1.23B | · | $-1.14B | |
| Liabilities + Equity | $1.22B | $1.37B | $936M | $998M | $1.08B | $882M | $919M | $665M | $794M | $849M | · | $655M | $504M | $626M | · | $729M | |
| Shares Outstanding | 195,284,352 | 195,707,702 | 194,771,957 | 192,633,286 | 191,162,659 | 189,826,023 | 190,044,473 | 188,986,547 | 188,032,738 | 187,122,744 | 175,082,951 | 174,131,954 | 161,419,931 | 160,435,238 | · | 149,367,087 |
Flusso di cassa 16
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Stock-based Comp | $44M | $33M | $35M | $35M | $37M | $26M | $30M | $27M | $21M | $17M | $37M | $23M | $27M | $22M | $22M | $17M | |
| Amort. of Intangibles | $700.0K | $700.0K | $700.0K | $700.0K | $700.0K | $600.0K | $600.0K | $600.0K | $600.0K | $600.0K | $600.0K | $600.0K | $600.0K | $600.0K | $300.0K | $600.0K | |
| Restructuring | · | · | · | · | · | · | · | $5M | $3M | $3M | · | $272.0K | $4M | $3M | $8M | $5M | |
| Other Non-cash | · | $-65M | · | · | · | $-57M | · | · | · | $-202M | · | · | · | $-25M | · | · | |
| Operating Cash Flow | $-71M | $-197M | $-56M | $-110M | $-81M | $-199M | $-195M | $-181M | $75M | $-220M | $-125M | $-145M | $-113M | $-144M | $-93M | $-135M | |
| CapEx | $443.0K | $69.0K | $33.0K | $470.0K | $594.0K | $0 | $47.0K | $137.0K | $54.0K | $695.0K | $435.0K | $431.0K | $428.0K | $12.0K | $801.0K | $759.0K | |
| Investing Cash Flow | $18M | $-43M | $-14M | $4M | $-13M | $-2M | $-3M | $38M | $3M | $23M | $-66.0K | $38M | $4M | $12M | $18M | $147M | |
| Debt Issued | · | · | · | · | · | · | · | $0 | $0 | $450M | · | $0 | $0 | $0 | · | · | |
| Net Debt Issued | · | · | · | · | · | $-459M | · | · | · | $-23M | · | · | · | · | · | · | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $0 | $-18.0K | $-495.0K | $315M | $-454.0K | $306M | $1M | $143M | $5M | $0 | |
| Stock Repurchased | $128M | $82M | $0 | $0 | $0 | $48M | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | · | $-82M | · | · | · | $-48M | · | · | · | $315M | · | · | · | $143M | · | · | |
| Financing Cash Flow | $-149M | $550M | $-2M | $-894.0K | $302M | $60M | $474M | $707.0K | $-6M | $280M | $-5M | $307M | $-1M | $150M | $6M | $1M | |
| Net Change in Cash | $-202M | $310M | $-73M | $-106M | $208M | $-141M | $275M | $-142M | $72M | $83M | $-129M | $199M | $-110M | $18M | $-69M | $13M | |
| Free Cash Flow | · | $-197M | · | · | · | $-199M | · | · | · | $-220M | · | · | · | $-144M | · | · |
Redditività 7
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -43.9% | -54.5% | · | -120.3% | -121.4% | -89.5% | · | -7018.7% | -8096.8% | 0.16% | · | -3854.6% | -8903.1% | -6909.3% | · | -38200.0% | |
| Net Margin | -64.0% | -85.6% | · | -153.2% | -166.2% | -145.4% | · | -6012.2% | -3484.5% | -17.1% | · | -4387.4% | -9793.0% | -7816.6% | · | -41477.2% | |
| Pretax Margin | -64.0% | · | · | -154.5% | -164.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -43.9% | -53.9% | · | -120.3% | -121.4% | -88.4% | · | -7018.7% | -8096.8% | 0.92% | · | -3854.6% | -8903.1% | -6819.8% | · | -38200.0% | |
| ROA | -13.6% | -14.8% | · | -22.2% | -19.6% | -19.6% | · | -24.9% | -11.6% | -4.9% | · | -25.9% | -23.5% | -19.8% | · | -18.6% | |
| ROE | 7.2% | 8.5% | · | 11.7% | 12.8% | 12.6% | · | 13.5% | 6.2% | 3.2% | · | 15.3% | 13.5% | 12.6% | · | 14.9% | |
| ROIC | 4.3% | · | · | 7.4% | 7.6% | · | · | · | · | · | · | · | · | · | · | · |
Liquidità e Solvibilità 5
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.5 | · | 3.9 | 5.2 | 4.6 | · | 3.2 | 4.6 | 5.5 | · | 5.5 | 3.9 | 5.7 | · | 5.4 | |
| Quick Ratio | 1.0 | 1.3 | · | 3.5 | 4.7 | 4.3 | · | 1.9 | 3.3 | 3.7 | · | 4.8 | 3.0 | 4.6 | · | 4.7 | |
| Debt / Equity | · | · | · | · | 0.0 | 0.0 | · | -0.4 | -0.4 | -0.4 | · | -0.4 | -0.3 | -0.4 | · | · | |
| LT Debt / Equity | · | · | · | · | 0.0 | 0.0 | · | -0.4 | -0.4 | -0.4 | · | -0.4 | -0.3 | -0.4 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -7.7 | 0.0 | · | -7.8 | -7.1 | -6.3 | · | -6.5 |
Efficienza 3
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.3 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.4 | 0.5 | · | 0.5 | 0.4 | 1.3 | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.5 | 1.2 | · | 2.1 | 2.8 | 2.0 | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 13
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $669M | $542M | · | $351M | $232M | $333M | · | $220M | $219M | $219M | · | $8M | $78M | $78M | · | $78M | |
| Net Income TTM | $-691M | $-705M | · | $-703M | $-593M | $-446M | · | $-455M | $-452M | $-519M | · | $-623M | $-446M | $-487M | · | $-505M | |
| Market Cap | $14.54B | $14.53B | · | $10.01B | $8.25B | $6.56B | · | $4.81B | $4.76B | $5.79B | · | $4.59B | $2.78B | $2.66B | · | $1.48B | |
| Enterprise Value | · | · | · | · | $7.50B | $6.02B | · | $4.98B | $4.75B | $5.70B | · | $4.53B | $2.88B | $2.65B | · | · | |
| P/E | -21.2 | -20.5 | · | -14.3 | -14.0 | -14.8 | · | -10.1 | -9.6 | -9.7 | · | -6.7 | -5.9 | -5.1 | · | -2.9 | |
| P/S | 21.7 | 26.8 | · | 28.5 | 35.6 | 19.7 | · | 21.9 | 21.7 | 26.5 | · | 581.5 | 35.8 | 34.3 | · | 19.0 | |
| P/B | -5.8 | -6.4 | · | -5.2 | -4.6 | -4.0 | · | -3.9 | -4.4 | -5.5 | · | -3.8 | -2.0 | -2.2 | · | -1.3 | |
| P / Cash Flow | · | -73.7 | · | · | · | -32.9 | · | · | · | -26.4 | · | · | · | -18.4 | · | · | |
| P / FCF | · | -73.6 | · | · | · | -32.9 | · | · | · | -26.3 | · | · | · | -18.4 | · | · | |
| EV / EBITDA | · | · | · | · | -55.8 | -58.4 | · | -26.0 | -27.1 | 2940.1 | · | -28.7 | -19.7 | -21.3 | · | · | |
| EV / FCF | · | · | · | · | · | -30.2 | · | · | · | -25.9 | · | · | · | -18.4 | · | · | |
| EV / Revenue | · | · | · | · | 32.3 | 18.1 | · | 22.6 | 21.7 | 26.1 | · | 573.5 | 37.2 | 34.2 | · | · | |
| Earnings Yield | -4.7% | -4.9% | · | -7.0% | -7.1% | -6.7% | · | -9.9% | -10.5% | -10.3% | · | -14.8% | -16.9% | -19.7% | · | -34.3% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $502M | $222M | $9M | $78M | $70M |
| Margine Operativo % | -104.2% | -267.2% | -6528.7% | -659.6% | -827.1% |
| Utile netto | $-733M | $-543M | $-653M | $-485M | $-586M |
| EPS Diluito | $-3.78 | $-2.88 | $-3.95 | $-3.26 | $-3.90 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | — | -0.3 | -0.3 | -0.3 | -0.5 |
| Rapporto corrente | 2.8 | 4.7 | 3.3 | 4.5 | 6.6 |
| Quick Ratio | 2.5 | 4.4 | 2.6 | 3.5 | 5.8 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-447M | $-522M | $-529M | $-424M | $-511M |
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 533 filer · $11.5B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 99 (-2 vs trimestre precedente) | 65 (+8 vs trimestre precedente) | 176 (0 vs trimestre precedente) | 161 (+14 vs trimestre precedente) | +15.1M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. | $987.677.120 | 13.260.971 | 8,61% | Azioni |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $800.143.332 | 10.743.063 | 6,97% | Azioni |
| VIKING GLOBAL INVESTORS LP | $741.017.831 | 9.949.219 | 6,46% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $588.315.509 | 7.898.973 | 5,13% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $570.272.655 | 7.656.722 | 4,97% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $360.280.689 | 4.837.281 | 3,14% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $351.708.339 | 4.722.185 | 3,06% | Azioni |
| Aisling Capital Management LP | $341.834.227 | 4.589.611 | 2,98% | Azioni |
| STATE STREET CORP | $330.388.215 | 4.435.932 | 2,88% | Azioni |
| UBS Group AG | $287.753.480 | 3.863.500 | 2,51% | Opzione Call |
| JANE STREET GROUP, LLC | $232.407.392 | 3.120.400 | 2,02% | Opzione Call |
| CITADEL ADVISORS LLC | $231.388.431 | 3.106.719 | 2,02% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $221.507.973 | 2.973.184 | 1,93% | Azioni |
| D. E. Shaw & Co., Inc. | $218.406.046 | 2.932.412 | 1,90% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $195.152.496 | 2.620.200 | 1,70% | Opzione Call |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $167.728.960 | 2.252.000 | 1,46% | Azioni |
| Polar Capital Holdings Plc | $153.697.598 | 2.063.609 | 1,34% | Azioni |
| FMR LLC | $152.985.495 | 2.054.048 | 1,33% | Azioni |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $145.662.994 | 1.955.733 | 1,27% | Azioni |
| SC US (TTGP), LTD. | $138.559.911 | 1.860.364 | 1,21% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $127.311.718 | 1.709.341 | 1,11% | Azioni |
| NORGES BANK | $126.152.213 | 1.693.773 | 1,10% | Azioni |
| Frazier Life Sciences Management, L.P. | $115.305.393 | 1.548.139 | 1,00% | Azioni |
| Point72 Asset Management, L.P. | $113.640.243 | 1.525.782 | 0,99% | Azioni |
| JANE STREET GROUP, LLC | $112.904.828 | 1.515.908 | 0,98% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $107.937.207 | 1.453.504 | 0,94% | Azioni |
| Pictet Asset Management Holding SA | $107.362.071 | 1.448.126 | 0,94% | Azioni |
| TWO SIGMA ADVISERS, LP | $107.165.167 | 1.401.035 | 0,93% | Azioni |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $102.265.291 | 1.373.057 | 0,89% | Azioni |
| Laurion Capital Management LP | $100.714.388 | 1.352.234 | 0,88% | Azioni |
| Hood River Capital Management LLC | $100.364.407 | 1.347.535 | 0,87% | Azioni |
| Balyasny Asset Management L.P. | $91.614.273 | 1.230.052 | 0,80% | Azioni |
| Squarepoint Ops LLC | $88.760.199 | 1.191.732 | 0,77% | Azioni |
| VANGUARD GROUP INC | $88.444.087 | 1.156.283 | 0,77% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $86.057.320 | 1.155.442 | 0,75% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $83.193.341 | 1.116.989 | 0,72% | Azioni |
| AMERIPRISE FINANCIAL INC | $82.434.273 | 1.106.795 | 0,72% | Azioni |
| PRIMECAP MANAGEMENT CO/CA/ | $75.670.190 | 1.015.980 | 0,66% | Azioni |
| FIL Ltd | $74.648.325 | 1.002.260 | 0,65% | Azioni |
| Clearbridge Investments, LLC | $73.966.324 | 993.103 | 0,64% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $73.400.040 | 985.500 | 0,64% | Opzione Put |
| GOLDMAN SACHS GROUP INC | $66.118.056 | 887.729 | 0,58% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $63.817.890 | 856.846 | 0,56% | Azioni |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $61.804.000 | 829.802 | 0,54% | Azioni |
| Ensign Peak Advisors, Inc | $56.677.567 | 760.977 | 0,49% | Azioni |
| Qube Research & Technologies Ltd | $54.162.228 | 727.205 | 0,47% | Azioni |
| Capital Research Global Investors | $52.143.969 | 700.107 | 0,45% | Azioni |
| BARCLAYS PLC | $51.071.756 | 685.711 | 0,44% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48.652.124 | 653.224 | 0,42% | Azioni |
| First Turn Management, LLC | $47.172.951 | 633.364 | 0,41% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $46.288.968 | 621.494 | 0,40% | Azioni |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | $46.261.390 | 621.125 | 0,40% | Azioni |
| BANK OF AMERICA CORP /DE/ | $41.878.465 | 562.278 | 0,36% | Azioni |
| Cormorant Asset Management, LP | $40.964.000 | 550.000 | 0,36% | Azioni |
| GILDER GAGNON HOWE & CO LLC | $40.884.008 | 548.926 | 0,36% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $36.316.001 | 487.594 | 0,32% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $35.176.457 | 472.294 | 0,31% | Azioni |
| NEUBERGER BERMAN GROUP LLC | $34.092.848 | 457.745 | 0,30% | Azioni |
| Catalio Capital Management, LP | $33.891.454 | 455.041 | 0,30% | Azioni |
| Bridgewater Associates, LP | $33.377.691 | 448.143 | 0,29% | Azioni |
| EVENTIDE ASSET MANAGEMENT, LLC | $32.557.442 | 437.130 | 0,28% | Azioni |
| Fisher Asset Management, LLC | $25.721.741 | 345.351 | 0,22% | Azioni |
| UBS Group AG | $25.687.705 | 344.894 | 0,22% | Azioni |
| BOONE CAPITAL MANAGEMENT LLC | $25.302.346 | 339.720 | 0,22% | Azioni |
| NOMURA HOLDINGS INC | $24.390.338 | 327.475 | 0,21% | Azioni |
| Weiss Asset Management LP | $23.847.304 | 320.184 | 0,21% | Azioni |
| Nicholas Investment Partners, LP | $23.200.073 | 311.494 | 0,20% | Azioni |
| Woodline Partners LP | $22.441.718 | 301.312 | 0,20% | Azioni |
| Candriam S.C.A. | $22.361.195 | 300.520 | 0,19% | Azioni |
| MACKENZIE FINANCIAL CORP | $22.227.811 | 298.440 | 0,19% | Azioni |
| Swiss National Bank | $21.941.808 | 294.600 | 0,19% | Azioni |
| CITADEL ADVISORS LLC | $21.278.936 | 285.700 | 0,19% | Opzione Call |
| CITADEL ADVISORS LLC | $20.943.776 | 281.200 | 0,18% | Opzione Put |
| Integral Health Asset Management, LLC | $20.482.000 | 275.000 | 0,18% | Azioni |
| NOMURA HOLDINGS INC | $19.811.680 | 266.000 | 0,17% | Opzione Call |
| PFM Health Sciences, LP | $18.870.104 | 253.358 | 0,16% | Azioni |
| FIRST TRUST ADVISORS LP | $18.451.526 | 247.738 | 0,16% | Azioni |
| SPHERA FUNDS MANAGEMENT LTD. | $18.273.370 | 245.346 | 0,16% | Azioni |
| MARSHALL WACE, LLP | $17.913.781 | 240.518 | 0,16% | Azioni |
| Caption Management, LLC | $17.726.240 | 238.000 | 0,15% | Opzione Call |
| Susquehanna Portfolio Strategies, LLC | $16.897.203 | 226.869 | 0,15% | Azioni |
| ExodusPoint Capital Management, LP | $16.752.563 | 224.927 | 0,15% | Azioni |
| NEW YORK STATE COMMON RETIREMENT FUND | $16.565.618 | 222.417 | 0,14% | Azioni |
| NAN FUNG TRINITY (HK) LTD | $16.327.133 | 219.215 | 0,14% | Azioni |
| ROYCE & ASSOCIATES LP | $16.272.912 | 218.487 | 0,14% | Azioni |
| VICTORY CAPITAL MANAGEMENT INC | $15.553.137 | 208.823 | 0,14% | Azioni |
| ALGERT GLOBAL LLC | $15.305.417 | 205.497 | 0,13% | Azioni |
| CITIGROUP INC | $14.598.080 | 196.000 | 0,13% | Opzione Put |
| California Public Employees Retirement System | $14.514.067 | 194.872 | 0,13% | Azioni |
| Longaeva Partners L.P. | $13.992.036 | 187.863 | 0,12% | Azioni |
| MIZUHO MARKETS AMERICAS LLC | $13.585.748 | 182.408 | 0,12% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $13.570.256 | 182.200 | 0,12% | Opzione Call |
| Cutter Capital Management, LP | $13.504.563 | 390.644 | 0,12% | Azioni |
| ADAR1 Capital Management, LLC | $13.159.797 | 176.689 | 0,11% | Azioni |
| BlackRock, Inc. | $12.997.803 | 174.514 | 0,11% | Azioni |
| RHUMBLINE ADVISERS | $12.750.043 | 171.188 | 0,11% | Azioni |
| ROYAL BANK OF CANADA | $12.654.000 | 169.892 | 0,11% | Azioni |
| Hillsdale Investment Management Inc. | $12.595.462 | 169.112 | 0,11% | Azioni |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $12.305.105 | 165.703 | 0,11% | Azioni |
| WCM INVESTMENT MANAGEMENT, LLC | $11.891.227 | 165.133 | 0,10% | Azioni |
Insider aziendali 25 insider · 9 dirigenti · 16 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Neil Kumar | Chief Executive Officer | 16 Agosto 2026 M | 278.307 | 0 | 4 | $-1.573.882 |
| Thomas Trimarchi | President and CFO | 16 Agosto 2026 F | 336.529 | 0 | 1 | $-2.089.887 |
| Brian C Stephenson | CFO and Treasurer | 25 Febbraio 2025 M | 102.464 | 0 | 0 | $0 |
| Brian M. Stolz | Chief Operating Officer | 16 Agosto 2020 M | 24.615 | 0 | 0 | $0 |
| Maricel Apuli | Chief Accounting Officer | 16 Agosto 2026 F | 122.687 | 0 | 1 | $-160.120 |
| Cameron Turtle | Senior Vice President, Portfolio Management and Corporate Development | 28 Dicembre 2020 M | 12.568 | 0 | 0 | $0 |
| Michael Thomas Henderson | Chief Business Officer | 15 Dicembre 2020 A | 274.211 | 0 | 0 | $0 |
| Uma Sinha | Chief Scientific Officer | 15 Dicembre 2020 A | 16.460 | 0 | 0 | $0 |
| Yi Ching Yau | Chief Accounting Officer | 16 Novembre 2020 M | 4.586 | 0 | 0 | $0 |
| Andrea Ellis | Direttore | 09 Luglio 2026 M | 22.579 | 0 | 1 | $-1.442.028 |
| Jennifer E. Cook | Direttore | 09 Luglio 2026 M | 8.383 | 0 | 6 | $-21.920.848 |
| Hannah Valantine | Direttore | 22 Giugno 2026 M | 9.259 | 0 | 2 | $-341.524 |
| Andrew Lo | Direttore | 22 Giugno 2026 A | 18.079 | 0 | 0 | $0 |
| Douglas A. Dachille | Direttore | 22 Giugno 2026 A | 10.579 | 0 | 0 | $0 |
| Ali J. Satvat | Direttore | 22 Giugno 2026 A | 169.983 | 0 | 0 | $0 |
| Eric Aguiar | Direttore | 22 Giugno 2026 A | 10.579 | 0 | 0 | $0 |
| Frank Mccormick | Direttore | 22 Giugno 2026 A | 10.579 | 0 | 1 | $-3.933.840 |
| James C Momtazee | Direttore | 22 Giugno 2026 A | 19.070 | 0 | 0 | $0 |
| Charles J Homcy | Direttore | 22 Giugno 2026 A | 919.876 | 0 | 0 | $0 |
| DANIELS RONALD J | Direttore | 22 Giugno 2026 A | 20.981 | 0 | 0 | $0 |
| Fred Hassan | Direttore | 22 Giugno 2026 A | 29.879 | 0 | 0 | $0 |
| Randal W Scott | Direttore | 20 Giugno 2025 A | 11.589 | 0 | 0 | $0 |
| Richard H Scheller | Direttore | 16 Febbraio 2023 M | 53.822 | 0 | 0 | $0 |
| Brent L Saunders | Direttore | 22 Giugno 2022 A | 17.600 | 0 | 0 | $0 |
| BridgeBio Pharma, Inc. | Proprietario del 10% | 26 Gennaio 2021 P | 1.000 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 5 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| KKR Genetic Disorder L.P., KKR Genetic Disorder GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×8 depositi | 17 Agosto 2026 | 4,70% | Modifica | Struttura del capitale | SEC |
| VIKING GLOBAL INVESTORS LP, Viking Global Opportunities Parent GP LLC, Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, HALVORSEN OLE ANDREAS, Shabet Rose Sharon ×13 depositi | 10 Luglio 2026 | 5,00% | Modifica | — | SEC |
| BridgeBio Pharma, Inc. ×6 depositi | 26 Gennaio 2021 | — | Deposito iniziale | M&A / vendita | SEC |
| Eidos Therapeutics, Inc. ×2 depositi | 26 Gennaio 2021 | — | Deposito iniziale | — | SEC |
| BridgeBio Pharma LLC ×4 depositi | 13 Dicembre 2018 | — | Deposito iniziale | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 79 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| CANC · Tema ETF Trust | 2,75% | 73.191 NS | 31 Maggio 2026 | N-PORT |
| HRTS · Tema ETF Trust | 2,59% | 20.327 NS | 31 Maggio 2026 | N-PORT |
| BBP · ETFis Series Trust I | 1,51% | 12.592 NS | 30 Aprile 2026 | N-PORT |
| SPIT · RBB Fund, Inc. | 1,37% | 5.527 NS | 30 Aprile 2026 | N-PORT |
| LFSC · RBB Fund, Inc. | 1,17% | 18.534 NS | 31 Maggio 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 1,11% | 49.222 NS | 30 Aprile 2026 | N-PORT |
| JSMD · Janus Detroit Street Trust | 1,06% | 145.924 NS | 30 Aprile 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,93% | 68.003 NS | 30 Aprile 2026 | N-PORT |
| ILDR · First Trust Exchange-Traded Fund VI… | 0,82% | 35.282 NS | 31 Maggio 2026 | N-PORT |
| GSC · Goldman Sachs ETF Trust | 0,73% | 27.974 NS | 31 Maggio 2026 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 0,73% | 2.214 NS | 31 Maggio 2026 | N-PORT |
| BIB · ProShares Trust | 0,64% | 7.167 NS | 31 Maggio 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 0,62% | 3.028 NS | 31 Maggio 2026 | N-PORT |
| PSC · Principal Exchange-Traded Funds | 0,60% | 188.692 NS | 30 Giugno 2026 | N-PORT |
| FDMO · FIDELITY COVINGTON TRUST | 0,58% | 69.186 NS | 30 Aprile 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,51% | 36.933 NS | 30 Aprile 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,49% | 20.355 NS | 31 Maggio 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0,41% | 18.338 NS | 30 Aprile 2026 | N-PORT |
| RSSL · Global X Funds | 0,34% | 68.833 NS | 30 Aprile 2026 | N-PORT |
| ITWO · ProShares Trust | 0,26% | 7.470 NS | 31 Maggio 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,26% | 49.007 NS | 30 Aprile 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,24% | 815.199 NS | 31 Maggio 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0,23% | 20.342 NS | 30 Aprile 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,23% | 77.319 NS | 30 Aprile 2026 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | 0,21% | 68.022 NS | 30 Aprile 2026 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0,21% | 459.045 NS | 31 Maggio 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,20% | 56.781 NS | 30 Aprile 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,19% | 28.343 NS | 31 Maggio 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,17% | 66.688 NS | 30 Aprile 2026 | N-PORT |
| UWM · ProShares Trust | 0,16% | 5.841 NS | 31 Maggio 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,15% | 10.157 NS | 30 Aprile 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,12% | 179 NS | 31 Maggio 2026 | N-PORT |
| URTY · ProShares Trust | 0,11% | 5.909 NS | 31 Maggio 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,06% | 6.286 NS | 31 Maggio 2026 | N-PORT |
| HDG · ProShares Trust | 0,05% | 148 NS | 31 Maggio 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,03% | 12.546 NS | 30 Aprile 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,03% | 45.958 NS | 31 Maggio 2026 | N-PORT |
| TILT · FlexShares Trust | 0,02% | 6.776 NS | 30 Aprile 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,02% | 883 NS | 31 Maggio 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,02% | 30.907 NS | 30 Aprile 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,02% | 106.480 NS | 30 Aprile 2026 | N-PORT |
| SCHK · SCHWAB STRATEGIC TRUST | 0,02% | 13.777 NS | 31 Maggio 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,02% | 99.331 NS | 31 Maggio 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,01% | 40.764 NS | 30 Aprile 2026 | N-PORT |
| AVLC · AMERICAN CENTURY ETF TRUST | 0,01% | 2.271 NS | 31 Maggio 2026 | N-PORT |
| GUSA · Goldman Sachs ETF Trust II | 0,01% | 4.130 NS | 31 Maggio 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 Luglio 2026 | Giornaliero |
| VB · VANGUARD INDEX FUNDS | — | — | 15 Luglio 2026 | Giornaliero |
| VBK · VANGUARD INDEX FUNDS | — | — | 15 Luglio 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 Luglio 2026 | Giornaliero |